Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors in COVID-19: Meta-analysis/Meta-regression Adjusted for Confounding Factors.

Two showed that continuing ARBs or ACE inhibitors was significantly associated with decreased mortality, 33 , 34 and one reported an OR that was substantially less than 1 but did not reach statistical significance. 35 Analyses by study type Among studies that reported only crude results (ie, with no adjustment for differences between groups in important prognostic factors) for mortality, the use of ARBs/ACE inhibitors was not significantly associated with mortality (OR 1.05 [95% confidence interval {CI}: 0.69, 1.61]; P = 0.82).

also in 111,027 other papers